Teriflunomide
A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme's t
Catalog Number | CS-O-05920 |
Alternative Name(s) | Leflunomide metabolite (A771726);N-(4-Trifluoromethylphenyl)no-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-beuteamide;N-(4-Trifluoromethylphenyl)no-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-beuteamide, LEF-M; A77 1726;CS-O-13277 |
Research Area | Metabolites |
Molecular Formula | C12H9F3N2O2 |
CAS# | 163451-81-8 |
Purity | >98% |
SMILES | FC(F)(C1=CC=C(NC(/C(C#N)=C(O)/C)=O)C=C1)F |
Size | 500 g |
Supplier Page | https://www.clearsynth.com/en/CSO05920.html |